IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Cuse
|
692 |
557K |
2 |
14/01/24 |
14/01/24 |
IPOs
|
692
|
557K
|
2
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Share Purchase Plan Supplementary Prospectus
|
|
Cuse
|
1 |
1.1K |
2 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
1
|
1.1K
|
2
|
|
ASX - By Stock
|
T92 |
Re:
Ann: Letter to Eligible Shareholders
|
|
Cuse
|
89 |
22K |
2 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
89
|
22K
|
2
|
|
ASX - By Stock
|
T92 |
Re:
Ann: Issue of Free Bonus Options
|
|
Cuse
|
27 |
7.2K |
0 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
27
|
7.2K
|
0
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Cuse
|
692 |
557K |
4 |
18/06/21 |
18/06/21 |
IPOs
|
692
|
557K
|
4
|
|
IPOs
|
|
Re:
nickel x
|
|
Cuse
|
5 |
2.4K |
3 |
09/04/21 |
09/04/21 |
IPOs
|
5
|
2.4K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
IPO - Chimeric Therapeutics Limited - 18 January 2021 #
|
|
Cuse
|
303 |
160K |
22 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
303
|
160K
|
22
|
|
IPOs
|
|
Re:
Accessing IPO's
|
|
Cuse
|
14 |
3.7K |
3 |
04/12/20 |
04/12/20 |
IPOs
|
14
|
3.7K
|
3
|
|
ASX - By Stock
|
LV1 |
Re:
IPO - Live Verdure Ltd - 8th December 2020 #
|
|
Cuse
|
89 |
30K |
5 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
89
|
30K
|
5
|
|
ASX - By Stock
|
PUA |
Re:
Ann: Trading Halt
|
|
Cuse
|
39 |
12K |
4 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
39
|
12K
|
4
|
|
ASX - By Stock
|
PUA |
Re:
Ann: Change in substantial holding
|
|
Cuse
|
39 |
10K |
6 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
39
|
10K
|
6
|
|
ASX - By Stock
|
TRI |
Re:
FDA approval (valuation)
|
|
Cuse
|
42 |
15K |
7 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
42
|
15K
|
7
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Extension of Entitlement Offer
|
|
Cuse
|
134 |
29K |
4 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
134
|
29K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Cholesterol-Lowering Drug Study Results
|
|
Cuse
|
54 |
13K |
8 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
54
|
13K
|
8
|
|
ASX - By Stock
|
KTG |
Re:
Ann: K-TIG to commence trading on the ASX
|
|
Cuse
|
247 |
126K |
21 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
247
|
126K
|
21
|
|
ASX - By Stock
|
OSX |
Re:
IPO - Osteopore Limited
|
|
Cuse
|
457 |
268K |
2 |
19/09/19 |
19/09/19 |
ASX - By Stock
|
457
|
268K
|
2
|
|
IPOs
|
|
Re:
K-TIG (KTG) - Alto Capital
|
|
Cuse
|
61 |
57K |
0 |
04/09/19 |
04/09/19 |
IPOs
|
61
|
57K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Ann: ASX Information for New Quoted Option Class
|
|
Cuse
|
8 |
2.5K |
0 |
29/08/19 |
29/08/19 |
ASX - By Stock
|
8
|
2.5K
|
0
|
|
IPOs
|
|
Re:
** Looking to list a company - advice wanted **
|
|
Cuse
|
19 |
18K |
0 |
16/08/19 |
16/08/19 |
IPOs
|
19
|
18K
|
0
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Change of Director's Interest Notice
|
|
Cuse
|
30 |
31K |
10 |
08/08/19 |
08/08/19 |
ASX - By Stock
|
30
|
31K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Cuse
|
65 |
38K |
3 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
65
|
38K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Medibio Partners with Digital Corporate Wellness Solution Leader WellteQ
|
|
Cuse
|
3 |
1.6K |
6 |
29/07/19 |
29/07/19 |
ASX - By Stock
|
3
|
1.6K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 3B & s708 notice
|
|
Cuse
|
11 |
9.6K |
5 |
27/07/19 |
27/07/19 |
ASX - By Stock
|
11
|
9.6K
|
5
|
|
ASX - By Stock
|
TRI |
Re:
Ann: MEB Raises $4.02m via Placement and Fully Underwritten SPP
|
|
Cuse
|
91 |
61K |
4 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
91
|
61K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
IXC Trading
|
|
Cuse
|
288 |
104K |
2 |
24/07/19 |
24/07/19 |
ASX - By Stock
|
288
|
104K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
New 52 Week High
|
|
Cuse
|
54 |
40K |
17 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
54
|
40K
|
17
|
|
ASX - By Stock
|
TRI |
Re:
Ann: MEB Raises $4.02m via Placement and Fully Underwritten SPP
|
|
Cuse
|
91 |
61K |
6 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
91
|
61K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Investor Presentation Evening...
|
|
Cuse
|
46 |
26K |
4 |
15/07/19 |
15/07/19 |
ASX - By Stock
|
46
|
26K
|
4
|
|
IPOs
|
IXC |
Re:
IXC - Invex Theraputics
|
|
Cuse
|
113 |
71K |
0 |
14/07/19 |
14/07/19 |
IPOs
|
113
|
71K
|
0
|
|
ASX - By Stock
|
SP3 |
Re:
Ann: Debt Facility No Longer Applicable
|
|
Cuse
|
31 |
12K |
5 |
09/07/19 |
09/07/19 |
ASX - By Stock
|
31
|
12K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Therapeutics Lists on ASX
|
|
Cuse
|
149 |
62K |
13 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
149
|
62K
|
13
|
|
ASX - Day Trading
|
|
Re:
Afternoon trading July 5
|
|
Cuse
|
326 |
56K |
1 |
05/07/19 |
05/07/19 |
ASX - Day Trading
|
326
|
56K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Becoming a substantial holder
|
|
Cuse
|
1 |
1.9K |
5 |
05/07/19 |
05/07/19 |
ASX - By Stock
|
1
|
1.9K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
how far will this go?
|
|
Cuse
|
82 |
52K |
7 |
04/07/19 |
04/07/19 |
ASX - By Stock
|
82
|
52K
|
7
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Cuse
|
692 |
557K |
6 |
28/06/19 |
28/06/19 |
IPOs
|
692
|
557K
|
6
|
|
ASX - By Stock
|
SP3 |
Re:
Ann: Spectur Reaches Agreement on $1m Debt Facility
|
|
Cuse
|
10 |
6.1K |
6 |
14/06/19 |
14/06/19 |
ASX - By Stock
|
10
|
6.1K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
options
|
|
Cuse
|
5 |
4.0K |
3 |
09/06/19 |
09/06/19 |
ASX - By Stock
|
5
|
4.0K
|
3
|
|
ASX - By Stock
|
ADO |
Re:
options
|
|
Cuse
|
5 |
4.0K |
6 |
09/06/19 |
09/06/19 |
ASX - By Stock
|
5
|
4.0K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Rights Issue Closed Oversubscribed
|
|
Cuse
|
221 |
61K |
28 |
05/06/19 |
05/06/19 |
ASX - By Stock
|
221
|
61K
|
28
|
|
International Markets
|
ETOs |
Re:
CBA International ETOs Caps/Fees
|
|
Cuse
|
1 |
8.1K |
0 |
16/05/19 |
16/05/19 |
International Markets
|
1
|
8.1K
|
0
|
|
ASX - By Stock
|
PUA |
Re:
Ann: Inside Briefing interview on Polar Sapphire acquisition
|
|
Cuse
|
93 |
33K |
15 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
93
|
33K
|
15
|
|
ASX - By Stock
|
NVQ |
Re:
Ann: Tymlez Operations Update
|
|
Cuse
|
46 |
23K |
13 |
18/02/19 |
18/02/19 |
ASX - By Stock
|
46
|
23K
|
13
|
|
ASX - By Stock
|
PUA |
Re:
Polar Sapphire Non-Binding Term Sheet
|
|
Cuse
|
114 |
41K |
16 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
114
|
41K
|
16
|
|
ASX - By Stock
|
NVQ |
Re:
Facebook and Google Take Another Step Into Crypto
|
|
Cuse
|
89 |
41K |
16 |
13/02/19 |
13/02/19 |
ASX - By Stock
|
89
|
41K
|
16
|
|
ASX - By Stock
|
NVQ |
Re:
Ann: TYMLEZ partnerships with EPI-USE for first BaaS Revenue
|
|
Cuse
|
167 |
84K |
15 |
17/01/19 |
17/01/19 |
ASX - By Stock
|
167
|
84K
|
15
|
|
ASX - By Stock
|
NVQ |
Re:
Ann: TYMLEZ partnerships with EPI-USE for first BaaS Revenue
|
|
Cuse
|
167 |
84K |
10 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
167
|
84K
|
10
|
|
ASX - By Stock
|
TYP |
Re:
Welcome to ASX Exopharm.
|
|
Cuse
|
62 |
38K |
6 |
17/12/18 |
17/12/18 |
ASX - By Stock
|
62
|
38K
|
6
|
|
ASX - By Stock
|
LPD |
Re:
Ann: Entitlement Offer Closes Significantly Oversubscribed
|
|
Cuse
|
84 |
45K |
22 |
28/09/18 |
28/09/18 |
ASX - By Stock
|
84
|
45K
|
22
|
|
ASX - By Stock
|
PUA |
Re:
Ann: Pre-feasibility Investor Presentation
|
|
Cuse
|
42 |
18K |
2 |
29/06/18 |
29/06/18 |
ASX - By Stock
|
42
|
18K
|
2
|
|
ASX - By Stock
|
ADT |
Re:
Updated Resource Estimate (based on current results)
|
|
Cuse
|
744 |
269K |
32 |
29/06/18 |
29/06/18 |
ASX - By Stock
|
744
|
269K
|
32
|
|